Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer (Q33366766)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q38290574)
(Q43285180)
(Q38524099)
(Q28500539)
(P304) 5314-5322
(P407) (Q1860)
(P433) 23
(P478) 23
(P577) Monday, June 13, 2005
(P921) (Q12859063)
(P1433) (Q400292)
(P1476) "Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer" (language: en)
(P2093) Max E Scheulen
Stephen Johnston
Klaus Mross
Christian Dittrich
Dagmar Hess
Rudolph Morant
Markus Borner
Marc Salzberg
Valerijus Ostapenko
Hans-Joachim Illiger
Dirk Behringer
Nathalie Bardy-Bouxin
Joseph Boni
Steven Kong
Maria Cincotta
Laurence Moore
other details
description scientific article

External Links